http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05001294-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3cd12257804e2d7f96cff826faa97e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
filingDate 2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2feecd1cc1211fd0ccd635ae9d7e6fc8
publicationDate 2005-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-PA05001294-A
titleOfInvention MEDICATION AND PROCESS FOR THE REDUCTION OF THE CONSUMPTION OF ALCOHOL AND / OR TOBACCO.
abstract The present invention relates to a medicament for the treatment of addiction, characterized in that the medicament is constituted by a combination of two forms of administration, by means of which at least one modulator of nicotinic receptors is continuously transferred to the patient and by means of another facilitates a rapid entry of galantamine to the central nervous system, as well as a two-stage process for the therapy of substance addiction by modulating neuronal nicotinic receptors, in which a permanent treatment is complemented based on a form of pharmaceutical administration, which continuously transfers a modulator of nicotinic receptors, with the administration, in case of appearance of a strong appetite for substance, galantanin or one of its pharmaceutically acceptable salts in a form of presentation, which facilitates a rapid entry of this modulator in the central nervous system.
priorityDate 2002-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 23.